Clinical trial Recruiting at 1 site Interventional Ages 8 to 65 Women only

Conmigo: a mother–daughter program to increase physical activity in pre-adolescent Latinas

Official title: A Multi-level Mother-daughter Physical Activity Intervention for Pre- Adolescent Latinas

Run by San Diego State University · NCT07088406 · Data updated 2026-11-12

This program tests whether a 10-week mother–daughter intervention called Conmigo can increase moderate-to-vigorous physical activity in Latina girls aged 8–11.

Quick facts

Study typeInterventional
Ages8 Years to 65 Years
SexWomen only
Enrollment432 (estimated)
SponsorSan Diego State University
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedAugust 21, 2025
Main results expectedAugust 31, 2029
Study endsAugust 31, 2029
Registry record updatedOctober 2, 2026
Trial IDNCT07088406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Latina girls aged 8–11 who are not meeting CDC physical activity guidelines, and their primary female caregivers who speak English or Spanish and can attend weekly 10‑week sessions at their elementary school, are ideal candidates.

Probably not a fit

Girls who already meet daily MVPA guidelines, mother–daughter pairs with medical conditions that preclude physical activity, or those unable to attend the weekly onsite sessions are unlikely to benefit from the program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm cluster randomized trial enrolling 216 Latina mother–daughter pairs across 18 elementary schools to compare a 10-week physical activity program (Conmigo) with a 10-week attention-control healthy eating program. Sessions are delivered weekly by trained YMCA staff at participating schools and include activity sessions for girls plus behavioral and family-level strategies involving mothers. The trial uses a Hybrid Type 1 effectiveness-implementation design and will measure daughters' moderate-to-vigorous physical activity (MVPA) over time while examining individual and family mechanisms of change. Outcomes will inform whether Conmigo increases MVPA and how the program could be scaled in school-community settings.

Why it matters

Potential benefit: If successful, Conmigo could help Latina girls increase daily moderate-to-vigorous physical activity, strengthen mother–daughter support for exercise, and reduce the early decline in activity that contributes to health disparities.

How similar studies have gone: Prior formative work and an R21 pilot showed promising increases in MVPA from Conmigo, but larger cluster randomized testing is needed to confirm effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (DAUGHTER):

* Self-identifying as Latina
* aged 8-11
* not currently meeting CDC's 2018 PA guidelines (60 min MVPA/day)
* attends an elementary school enrolled in the study
* speaks English or Spanish

Inclusion Criteria (MOTHER):

* Self-identifying as Latina
* primary female caregiver (living with her ≥4 days/week) of the daughter
* speaks English or Spanish
* both Mother \& Daughter can attend weekly program activities for 10 weeks, and intend to stay in the area for the study's duration.

Exclusion criteria:

* either Mother or Daughter has a health condition that precludes them from doing PA
* cognitive impairment affecting participation,
* inability for mother to provide informed consent or daughter to provide assent in English or Spanish

Where it's running

  • San Diego State University
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.